trending Market Intelligence /marketintelligence/en/news-insights/trending/xtnjheug3i-ktderrpqrfw2 content esgSubNav
In This List

WuXi Biologics to build manufacturing facility in northern China

Blog

Insight Weekly: US bank stress tests; cracks in housing market; summer energy supply risks

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches


WuXi Biologics to build manufacturing facility in northern China

WuXi Biologics (Cayman) Inc. said it will build an integrated biologics facility in Shijiazhuang, the capital of China's Hebei province.

Biologics centers develop and manufacture biologic medical products using living microorganisms, plants or animal cells.

WuXi Biologics said the initial phase of the center is expected to be operational in 2020.

China-based WuXi Biologics is a provider of discovery, research, development and manufacturing of biologics services.